Quest Diagnostics completes acquisition of laboratory services business of Boyce & Bynum Pathology Laboratories

Staff - Print  | 

A recent press release by Quest Diagnostics announced that it has completed its acquisition of the clinical laboratory services business of Boyce & Bynum Pathology Laboratories. 

Editor's Note: This article originally appeared on Quest Diagnostics' website

Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has completed its previously announced acquisition of the clinical laboratory services business of Boyce & Bynum Pathology Laboratories (BBPL), a leading provider of diagnostic and clinical laboratory services in the Midwest.

Through a separate professional services agreement, Boyce and Bynum Pathology Professional Services, Inc. (BBPPS), is now the exclusive pathology provider for Quest Diagnostics clients in Missouri and a preferred pathology provider in the greater Midwestern region. Additional financial terms were not disclosed. Click here to continue>>

 

News From Our Partners 

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.